Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioanna Vasileiou

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Reviews on Recent Clinical Trials|December 25, 2012
The treatment of iatrogenic male incontinence: latest results and future perspectivesIoannis Adamakis, Ioanna Vasileiou, Constantinos A Constantinides
Journal of Applied Toxicology : JAT|January 9, 2013
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effectsPanagiotis Zogopoulos, Ioanna Vasileiou, Efstratios Patsouris, et al.
Nutrition Research (New York, N.Y.)|July 30, 2013
Current clinical status on the preventive effects of cranberry consumption against urinary tract infectionsIoanna Vasileiou, Athanasios Katsargyris, Stamatios Theocharis, et al.
Expert Opinion on Therapeutic Targets|June 11, 2013
Ephrins and painIoanna Vasileiou, Ioannis Adamakis, Efstratios Patsouris, et al.
Fundamental & Clinical Pharmacology|January 15, 2010
Insight into pain-inducing and -related gene expression: a challenge for development of novel targeted therapeutic approachesIoanna Vasileiou, Constantinos Giaginis, Chris Klonaris, et al.
Journal of Applied Toxicology : JAT|August 14, 2012
Ghrelin and toxicity: recent findings and future challengesIoanna Vasileiou, Demetrios Patsouras, Efstratios Patsouris, et al.
Fundamental & Clinical Pharmacology|January 3, 2013
The role of endocannabinoids in pain modulationPanagiotis Zogopoulos, Ioanna Vasileiou, Efstratios Patsouris, et al.
Expert Opinion on Therapeutic Targets|January 9, 2013
Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseasesIoanna Vasileiou, Georgia Fotopoulou, Marina Matzourani, et al.
Expert Opinion on Therapeutic Targets|December 5, 2014
FAK/Src family of kinases: protective or aggravating factor for ischemia reperfusion injury in nervous system?Christos Bikis, Demetrios Moris, Ioanna Vasileiou, et al.
Fundamental & Clinical Pharmacology|July 21, 2011
Management of the airway without the use of neuromuscular blocking agents: the use of remifentanilGeorgia Fotopoulou, Stamatios Theocharis, Ioanna Vasileiou, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Reviews on Recent Clinical Trials|December 25, 2012
The treatment of iatrogenic male incontinence: latest results and future perspectivesIoannis Adamakis, Ioanna Vasileiou, Constantinos A Constantinides
Journal of Applied Toxicology : JAT|January 9, 2013
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effectsPanagiotis Zogopoulos, Ioanna Vasileiou, Efstratios Patsouris, et al.
Nutrition Research (New York, N.Y.)|July 30, 2013
Current clinical status on the preventive effects of cranberry consumption against urinary tract infectionsIoanna Vasileiou, Athanasios Katsargyris, Stamatios Theocharis, et al.
Expert Opinion on Therapeutic Targets|June 11, 2013
Ephrins and painIoanna Vasileiou, Ioannis Adamakis, Efstratios Patsouris, et al.
Fundamental & Clinical Pharmacology|January 15, 2010
Insight into pain-inducing and -related gene expression: a challenge for development of novel targeted therapeutic approachesIoanna Vasileiou, Constantinos Giaginis, Chris Klonaris, et al.
Journal of Applied Toxicology : JAT|August 14, 2012
Ghrelin and toxicity: recent findings and future challengesIoanna Vasileiou, Demetrios Patsouras, Efstratios Patsouris, et al.
Fundamental & Clinical Pharmacology|January 3, 2013
The role of endocannabinoids in pain modulationPanagiotis Zogopoulos, Ioanna Vasileiou, Efstratios Patsouris, et al.
Expert Opinion on Therapeutic Targets|January 9, 2013
Evidence for the involvement of cannabinoid receptors' polymorphisms in the pathophysiology of human diseasesIoanna Vasileiou, Georgia Fotopoulou, Marina Matzourani, et al.
Expert Opinion on Therapeutic Targets|December 5, 2014
FAK/Src family of kinases: protective or aggravating factor for ischemia reperfusion injury in nervous system?Christos Bikis, Demetrios Moris, Ioanna Vasileiou, et al.
Fundamental & Clinical Pharmacology|July 21, 2011
Management of the airway without the use of neuromuscular blocking agents: the use of remifentanilGeorgia Fotopoulou, Stamatios Theocharis, Ioanna Vasileiou, et al.
Pageof 3